Cargando…
Effect of Apremilast on LPS-induced immunomodulation and inflammation via activation of Nrf2/HO-1 pathways in rat lungs
Lipopolysaccharides (LPS), the lipid component of gram-negative bacterial cell wall, is recognized as the key factor in acute lung inflammation and is found to exhibit severe immunologic reactions. Phosphodiesterase-4 (PDE-4) inhibitor: “apremilast (AP)” is an immune suppressant and anti-inflammator...
Autores principales: | Al-Harbi, Naif O., Imam, Faisal, Al-Harbi, Mohammad Matar, Qamar, Wajhul, Aljerian, Khaldoon, Khalid Anwer, Md., Alharbi, Mohammed, Almudimeegh, Sultan, Alhamed, Abdullah S., Alshamrani, Ali A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267521/ https://www.ncbi.nlm.nih.gov/pubmed/37323920 http://dx.doi.org/10.1016/j.jsps.2023.05.022 |
Ejemplares similares
-
Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation
por: Al-Harbi, Naif O., et al.
Publicado: (2022) -
Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs
por: Imam, Faisal, et al.
Publicado: (2020) -
Geraniol Ameliorates Doxorubicin-Mediated Kidney Injury through Alteration of Antioxidant Status, Inflammation, and Apoptosis: Potential Roles of NF-κB and Nrf2/Ho-1
por: AlAsmari, Abdullah F., et al.
Publicado: (2022) -
The possible impact of socioeconomic, income, and educational status on adverse effects of drug and their therapeutic episodes in patients targeted with a combination of tuberculosis interventions
por: Imam, Faisal, et al.
Publicado: (2021) -
Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors
por: AlHarbi, Atika, et al.
Publicado: (2022)